| Lymph node metastasis | Primary site recurrence | Distant metastasis | OSCC death 7 |
---|---|---|---|---|
Gene expression ratio | Â | Â | Â | Â |
High-ITGA3/CD9 | 0.000 | 0.005 | 0.001 | 0.000 |
High-ITGB4/JUP | 0.022 | 0.237 | 0.000 | 0.001 |
Clinicopathological parameter | Â | |||
Age1 | 0.449 | 0.321 | 0.207 | 0.365 |
Sex | 0.417 | 0.858 | 0.149 | 0.584 |
Size2 | 0.000 | 0.007 | 0.703 | 0.084 |
T3-43 | 0.000 | 0.000 | 0.390 | 0.092 |
YK44 | 0.000 | 0.018 | 0.001 | 0.000 |
Positive margin5 | ------ | 0.000 | 0.427 | 0.000 |
Clinical event | Â | |||
Lymph node metastasis6 | ------ | 0.001 | 0.000 | 0.000 |
Primary site recurrence | ------ | ------ | 0.840 | 0.000 |
Distant metastasis | ------ | ------ | ------ | 0.000 |